Purpose: The aim of this study was to investigate the association between preexisting cerebral abnormalities in patients with acute ischemic stroke upon their functional outcomes. Methods: We recruited 272 patients with first-ever acute ischemic stroke. Cerebral abnormalities on magnetic resonance imaging included infarction, silent brain infarcts (SBI), enlarged perivascular spaces, white matter lesions (WMLs), global brain atrophy, and medial temporal lobe atrophy (MTLA). Functional outcomes were assessed using the instrumental activities of daily living (IADL) scale and basic activities of daily living (BADL) scale, at 3 and 6 months after the index stroke. Results: Two hundred and fifty patients completed the 3-month follow-up and 246 patients completed the 6-month follow-up. Univariate analyses showed that patients with poor IADL and BADL were older, more likely to be men, had higher National Institutes of Health Stroke Scale (NIHSS) score on admission, more frequent atrial fibrillation, and large artery atherosclerosis subtypes. They also had more frequent cortical infarcts, subcortical infarcts, infratentorial infarcts, larger infarct volume, more frequent presence of SBI, severe WMLs, and MTLA. In multiple regression analyses, NIHSS on admission, subcortical region infarct and MTLA were significant predictors of poor IADL at 3 months. National Institutes of Health Stroke Scale on admission, SBI and MTLA were significant predictors of poor IADL at 6 months. National Institutes of Health Stroke Scale on admission and MTLA were significant predictors of poor BADL at 3 months. National Institutes of Health Stroke Scale on admission and SBI were significant predictors of poor BADL at 6 months. Conclusions: In patients with acute ischemic stroke, the presence of SBI, and severe MTLA represent significant predictors of poorer functional outcomes, thus highlighting the importance of preexisting cerebral abnormalities.
Introduction
Stroke is one of the most significant global diseases and is associated with high mortality rates, and high levels of disability and handicap among survivors. 1 According to a recently published report, investigating the global burden of diseases, the lifetime stroke risk in the Chinese population is estimated to be 39.3%, and is the highest in the world. 2 The severity of neurological deficits immediately following an acute ischemic stroke is considered to be the most important predictor of clinical outcomes. However, there is limited evidence to suggest that preexisting cerebral abnormalities (PCAs) may also affect poststroke outcomes. Preexisting cerebral abnormalities include silent brain infarcts (SBI), white matter changes, enlarged perivascular spaces (EPVS), and brain atrophy, events which can be revealed by magnetic resonance imaging (MRI). For instance, some studies found that EPVS are associated with both poststroke depression 2 and cognitive impairment. 3 Another study found that white matter changes were the major driving factor associated with poor outcomes, as assessed by the modified Rankin Scale. 4 However, the outcome measures used in these previous studies were not necessarily robust or comprehensive. Functional status involves the instrumental activities of daily living (IADL) and the basic activities of daily living (BADL). These are vital parameters to consider and have been used widely in the study of strokes. 5 Instrumental activities of daily living involves several different multidimensional components, such as managing finance, shopping, and preparing meals. 6 For a patient to be independent, he/she must have an adequate IADL score. A reduction or loss of IADL performance is eventually followed by a significant decline in BADL. 7 Consequently, IADL and BADL can allow us to evaluate the impairment of function in a very direct and precise manner. In the present study, we set out to investigate the effect of PCAs on functional outcomes measured by IADL scale and BADL scale at different time points following an acute ischemic stroke.
Methods

Participants and Study Setting
Between January 1, 2017, and December 30, 2017, patients with acute ischemic stroke were consecutively recruited from Division I, Department of Neurology, Dongguan People's Hospital. The inclusion criteria for the study were as follows: (1) patient was aged over 18 years; (2) patient had experienced their first-ever acute ischemic stroke occurring within 7 days before admission; (3) patient had received a complete brain MRI examination. Patients were excluded from the study if they were associated with any of the following factors: (1) transient ischemic attack, cerebral hemorrhage, subdural hematoma, or subarachnoid hemorrhage; (2) a history of strokes; (3) severe prestroke cognitive impairment as assessed by the Informant Questionnaire on Cognitive Decline in the Elderly score (IQCODE)> 51 points 8 ; (4) lack of complete clinical and MRI data (eg, brain MRI results without complete sequences or images were of poor quality); (5) death during hospitalization; (6) the patients or their relatives refused to provide signed and informed consent; (7) patients had other severe diseases, such as severe organ dysfunction, or a malignant tumor. The study protocol was approved by the Ethics Committee of Dongguan People's Hospital and all patients provided informed written consent as required by the Declaration of Helsinki.
Demographic Data Assessment and Collection
The demographic and clinical variables included age, gender, vascular risk factors, neurological deficit status, which were assessed using the National Institutes of Health Stroke Scale (NIHSS) and treatment. The ischemic stroke subtype was judged in accordance with the Trial of Org 10172 in Acute Stroke Treatment 9 subtype system by the attending neurologist during hospitalization. Preexisting cognitive status was assessed by the IQCODE 10 within 3 days after admission. The IQCODE questionnaire consists of 16 items and requires the informant to indicate whether the patient has cognition declined or not over the previous 10 years. The score of the IQCODE questionnaire ranges from 16 (much improvement on all items) to 80 (much worsening on all items). A total score> 51 points was judged as preexisting cognitive decline.
Magnetic Resonance Imaging Assessment
Brain MRI scanning, including T1 weighted imaging, T2 weighted imaging, and diffusion-weighted imaging (DWI), was performed on each participant using a 3.0-T system (Sonata, Siemens Medical, Erlangen, Germany) within 7 days of admission. Diffusion-weighted images, spin echo (SE), and echo-planar images (EPI) were also obtained using A neurologist (W-L), who was blind to the patient's clinical information, conducted the assessment. The MRI variables included acute infarction and preexisting abnormalities, as follows:
1. Acute infarction: We assessed both the site and volume of acute lesions in the DWI sequence. The sites of the acute infarcts were classified into cortical regions, subcortical regions, and infratentorial regions. 11 The cortical lesions included the frontal, temporal, parietal, and occipital lobes; the subcortical regions included the white matter, basal ganglia (BG), and thalamus, while the infratentorial regions included the brainstem and cerebellum. Acute infarcts were defined as areas of restricted water diffusion identified on DWI with b values of 1000 together with hypointensity on the corresponding apparent diffusion coefficient map. The total area of acute infarcts on DWI was measured using manual outlines. The total volume was calculated by multiplying the total area by the sum of the slice thickness and the gap. 2. Silent brain infarcts: SBI are defined as a cerebral infarction evident on brain imaging, which do not exhibit overt clinical manifestations, such as rapidly developing clinical symptoms and signs of focal loss in brain function. 12 Most SBI are lacunae, which are visible as focal lesions with approximately the same intensity as cerebrospinal fluid on MRI with a diameter > 3 mm. 13 3. Enlarged perivascular spaces: According to the Standards for Reporting Vascular changes on Euroimaging guidelines, EPVS are defined as fluid-filled spaces with a signal intensity similar to that of cerebrospinal fluid on all sequences, which follow the course of penetrating vessels, are linear, round, or ovoid in shape, without a hyperintense rim to distinguish them from small lacunes and generally with a diameter <3 mm. 14 Enlarged perivascular spaces are detectable as punctate or linear hyperintensity on T2 weighted MRI, particularly in the BG and centrum semiovale (CS). 14, 15 Enlarged perivascular spaces of small diameter (<3 mm) are often numerous and therefore impractical to count. In the present study, the severity of EPVS in the CS (CS-EPVS) and BG (BG-EPVS) was rated according to the number of spaces in a slice from one side containing the maximum amount of EPVS: 0 ¼ none; 1 ¼ 1-10; 2 ¼ 11-20; 3 ¼ 21-40; 4 ¼ >40. 15, 16 We also calculated the total burden of the EPVS (Total-EPVS) by creating a total score for the BG and CS. 4. White matter lesions (WMLs). The severity of WMLs was graded using the 4-point scale described by Fazekas et al. 17 White matter lesions included periventricular hyperintensities (PVH) and deep white matter hyperintensities (DWMH), which were scored separately on fluid-attenuated inversion recovery images. 5. Global brain atrophy. This was assessed by ventricularbrain ratio (VBR). Axial TI-weighted images were chosen as measures of VBR. Measurements included the width of the body of the lateral ventricles at the waist (a), halfway from the anterior to posterior extent of ventricles, and the width of the brain at that level (b). Ventricular-brain ratio was then calculated as (a) divided by (b). 18 6. Medial temporal lobe atrophy (MTLA). This was evaluated using Schelten scale. 19 The MRI rater judged the severity of MTLA based on standard images of the coronary section of the MRI (range: 0-4), with 0 representing no atrophy and 4 severe atrophy.
Intrarater reliability (k) tests were carried out on 10 patients with stroke by the same MRI rater. The intrarater agreement for the MRI measurements was good to excellent: volume of infarction-ICC: 0.82; EPVS: 0.83; white matter hyperintensities: 0.82; VBR-ICC: 0.82; MTLA: 0.86.
Patient Follow-Up
All participants were followed up for 3 and 6 months after the index stroke via telephone conversations with the patients (n ¼ 176) or their relatives (n ¼ 74) by J-F.Q. Functional status was assessed using the Lawton activities of daily living scale, 20 which is composed of the IADL scale and the BADL scale. The IADL examines a person's present functional level and identifies improvement or deterioration over time. The 8 domains of function measured by the IADL include the ability to use a telephone, shopping, food preparation, housekeeping, laundry, mode of transportation, responsibility for own medications, and the ability to handle finances. The total IADL score is calculated by summing up the points obtained for each item and the maximum IADL score is 32. The BADL features 6 additional questions measuring different levels of ability for toilet activity, feeding, dressing, grooming, physical ambulation, and bathing. The total score of the BADL is calculated by summing up the points obtained for each item; the maximum score is 24. A higher IADL or BADL score reflects poorer IADL or BADL performance. We defined a poor functional outcome as a score higher than the 75% quartile of the IADL and BADL score. At the same time, we also assessed disability at 3 and 6 months according to the modified Rankin Scale. We also recorded any instances of stroke recurrence or death, during the follow-up period.
Statistical Analysis
All statistical analyses were carried out using SPSS for Windows (version 24.0; SPSS Inc, Chicago, Illinois). Descriptive data are presented as proportions, means, or medians, as appropriate. The normality of variables was tested with a one-sample Kolmogorov-Smirnov test. Univariate analyses comparing putative clinical and MRI risk factors between patients with favorable and poor IADL and BADL were performed at 3 months and 6 months, respectively. In the logistic regression analysis, we used a backward elimination procedure. The poor outcomes served as dependent variables. Then, risk factors with a value of P < .05 were analyzed by multivariate logistic regression analysis. Correlations analyses were conducted to test collinearity between the candidate independent variables. If the correlation coefficient between any of these putative risk factors was !0.50, then variables with a smaller P value were entered into the logistic regression. The level of significance was set at 0.05 (2-sided).
Results
Four hundred and fifty-three patients with their first or recurrent acute ischemic stroke were admitted during the study period. Of the 453 patients, 67 patients were excluded because of the absence of MRI examination. A total of 42 patients with previous history of stroke (n ¼ 30 with cognitive decline, n ¼ 12 without cognitive decline) were also excluded. Thirty-nine patients were excluded because their MRI sequences were incomplete. Other reasons included the following: 3 patients died during hospitalization, 2 patients were younger than 18 years of age, 21 patients were transferred to another department because of severe complications, and 7 patients refused to provide informed consent. Therefore, 272 patients were eventually included in the final analyses (Figure 1) .
The baseline characteristics of the patients are summarized in Table 1 . The study sample consisted of 190 (69.9%) men and 82 (30.1%) women, with a mean age of 61.5 + 14.6 years (range, 19-91 years). The distribution of age is presented in Figure 2 . The median NIHSS at the time of first screening upon admission was 4 (range, 0-28).
Subsequently, 2 patients died, and 20 patients were lost to follow-up by the 3-month time point. Thus, 250 patients were included in our analyses. A further 4 patients were lost to follow-up. Thus, in total, 246 patients were evaluated over a 6-month period.
Univariate Correlates of IADL and BADL
The characteristics of clinical and MRI variables are shown in Table 1 . A poorer IADL and BADL was related to older age; male gender; atrial fibrillation; a higher NIHSS score on admission; stroke subtype; infarct volume; cortical, subcortical, and infratentorial region infarcts; the presence of silent old infarcts, severe WMLs, and MTLA at 3 months and 6 months (Tables 2 and 3 ).
Multiple Logistic Regression Analyses of Poor IADL and BADL
Multiple logistic regression models are presented in Tables 4  and 5 . Infarct volume was not included in the model as it was highly correlated with NIHSS score on admission (r ¼ 0.535). Deep white matter hyperintensity was not included in the model as it was highly correlated with PVH (r ¼ 0.748). Infratentorial region infarcts were not included in the model as it was highly correlated with subcortical region infarcts (r ¼ À0.551). Although age was highly correlated with PVH and had a bigger P value, it is recognized as being highly correlated with functional outcomes and was still included in the model. At 3 months, NIHSS on admission, subcortical region infarct and MTLA were significant predictors of poor IADL and fitting for 54.4% of the model. National Institutes of Health Stroke Scale on admission, SBI and MTLA were significant predictors of poor IADL at 6 months, and fitting for 48.2% of the model. National Institutes of Health Stroke Scale on admission and MTLA were significant predictors of poor BADL at 3 months, fitting for 46.7% of the model. National Institutes of Health Stroke Scale score on admission and SBI were significant predictors of poor BADL at 6 months, fitting for 39.9% of the model.
Discussion
In this current longitudinal observational study, we investigated PCAs by MRI, and studied their effect on the functional outcomes of Chinese patients suffering from acute ischemic stroke. Our main finding was that preexisting SBI on MRI, and a more severe MTLA, might predict poorer IADL and BADL at 3 and 6 months after stroke. In the present study, the presence of SBI on MRI increased the level of prediction for a poor performance in the IADL and BADL. Silent brain infarcts are common in healthy elderly people. In particular, patients with vascular factors, such as hypertension, diabetes mellitus, chronic renal failure, or atrial fibrillation commonly exhibit a high loading of SBIs. 21 In the acute phase, SBI may be associated with more severe neurological deficits. 22 At the same time, SBIs are associated with an increased risk of subsequent stroke in patients with minor stroke and atrial fibrillation. 23 The results of the Rotterdam Scan Study also showed that the presence of SBI more than doubles the risk of mild cognitive impairment 24 or dementia upon follow-up, including Alzheimer's disease on follow-up. 25 Cognitive decline may impair performance on the activities of daily living. We hypothesized that impaired activities of daily living may be caused by cognitive impairment and putative increased risk for stroke related to SBI.
Brain atrophy is an important form of PCA in elderly stroke patients. We investigated the association between functional outcomes and brain atrophy (global atrophy and regional atrophy, eg, MTLA). A previous meta-analysis found that brain atrophy was associated with increased death rates and poor outcome when assessed 6 months after an index stroke. 26 However, a subsequent study obtained contrasting results. 27 Our study indicated that a more severe form of MTLA, rather than global atrophy, might be a more reliable predictor for poor IADL. The clinical significance of global brain atrophy in stroke patients remains unclear, while the tolerance of different brain regions to vascular lesions is different. Compared with global brain atrophy, the medial temporal lobe is a region which is more susceptible to ischemia. 28 Consequently, it may be more meaningful to assess the degree of MTLA in acute ischemic stroke.
In addition, many of the current studies focus on the relationship between MTLA and poststroke cognitive impairment. A previous study found that chronic brain changes, including WMLs and MTLA, are associated with incident dementia after stroke. 6 However, another research study showed that the association of MTLA, but not WMLs with subsequent cognitive decline and increasing brain atrophy suggests a more significant role for Alzheimer's than vascular pathology in delayed cognitive impairment after stroke. 28 Our present study demonstrated a strong association between MTLA and IADL. Medial temporal lobe atrophy is commonly regarded as a marker for the pathology associated with Alzheimer's, although this may also be present in vascular dementia, 19 resulting in the impairment of memory. Complete IADL requires intact cognitive function, such as memory, executive, and visuospatial functions.
11
Although we excluded patients with preexisting dementia, the IQCODE cannot accurately identify patients with mild cognitive impairment. Previous literature has shown that patients experiencing mild cognitive impairment or vascular mild cognitive impairment with MTLA have a significantly higher risk of future dementia. 29 Therefore, the patients with MTLA in our population may have a certain degree of cognitive impairment on the basis that their cerebral function compensatory ability may have decreased. On the basis of acute stroke, cognitive function may have deteriorated significantly, thus affecting the recovery of overall function and resulting in the impairment of IADL. Surprisingly, age is not an independent risk factor for the functional outcomes in the present study. Most studies report an increased risk associated with older age. One reason for not confirming this finding might be the strong relationship between age and PVH. A previous study reported age and WMLs as risk factors for poor outcomes, 4 but did not adjust for other PCAs, such as MTLA and SBI; furthermore, this study focused on physical function outcomes but not the IADL and BADL. As the previous studies did not measure the relationship between MTLA and functional outcomes, we speculate that MTLA, but not age, might be a better predictor for poor functional outcomes.
There are 2 main advantages to our study. First, this study was prospective and included the consecutive recruitment of patients. Second, we conducted comprehensive neuroimaging assessment for all participants, including EPVS, WMLs, SBI, VBR, and MTLA. There are also several limitations to the current study which need to be considered. First, the sample size was relatively small. Second, although we had excluded dementia prior to stroke, we did not evaluate the cognitive status of patients during the follow-up period; this might act as a mediator between PCAs and IADL. Third, we did not assess the NIHSS at follow-up, resulting in an inadequate evaluation of residual neurological deficits poststroke. Fourth, the cerebral abnormalities might not only represent one of respect of them, so a total burden might be a better predictor. To the best of our knowledge, the most common brain abnormality burden is that created by small vascular diseases, which include cerebral microbleeds. As we did not assess cerebral microbleeds in the present study, we did not consider the total burden.
In conclusion, PCAs, including the presence of SBI and severe MTLA, might predict a poorer functional outcome in patients with acute ischemic stroke, indicating that the compensational and functional reserve of the brain can be crucial for the prognosis of stroke. Further prospective studies, with a larger sample size and longer follow-up period, are now warranted to clarify the link between these abnormalities and activities of daily living performance.
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